The surgical mesh, called CeraFix Dural Substitute, is intended to improve neurosurgical procedures. The company is also working on other mesh products for hernia surgery and orthopedic surgery.
The company has, thus far, raised $1.3 million from investors, and it is looking to raise another $700,000 for further developments, according to the report.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
